0001104659-23-001399.txt : 20230105 0001104659-23-001399.hdr.sgml : 20230105 20230105160542 ACCESSION NUMBER: 0001104659-23-001399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SKELLY WILLIAM G CENTRAL INDEX KEY: 0001058352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 23511278 MAIL ADDRESS: STREET 1: C/O ACURA PHARMACEUTICALS, INC. STREET 2: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tm231734-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-03 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001058352 SKELLY WILLIAM G ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 1 0 0 0 Common Stock 2023-01-03 4 M 0 66666 A 525989 D Restricted Stock Units (2021 Plan) 2023-01-03 4 M 0 66666 D Common Stock 66666 0 D Restricted Stock Units (2021 Plan) 2023-01-03 4 A 0 50000 D Common Stock 50000 50000 D Represents exchange of restricted stock units. Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock Does not include Restricted Stock Units. 1 - for - 1 66,666 Restricted Stock Units were granted on January 3, 2022. 25% of Restricted Stock Units vested on the last day of each of March, June, September and December 2022. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value. N/A 50,000 Restricted Stock Units were granted on January 3, 2023. 25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2023, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2024, or earlier upon a change of control. /s/ William Skelly 2023-01-05